Precio FOB
Obtener el precio más reciente|
10 Kilogram Minimum Order
País:
China
N º de Modelo:
-
Precio FOB:
Lugar de origen:
China
Precio de pedido mínimo:
-
Cantidad de pedido mínimo:
10 Kilogram
Detalle de embalaje:
10kg/fabric drum, or customized
El tiempo de entrega:
30 days
Capacidad de suministro:
30000 Kilogram per Year
Tipo de pago:
T/T, L/C, D/P
Grupo de productos :
China
Persona de contacto Olivia
Nanjing, Jiangsu
Edaravone is a novel free radical scavenger and was the first
neuroprotective agent that was clinically used for the treatment of
acute cerebral infarction. In May 2017, US FDA is approved
Edaravone for the treatment of amyotrophic lateral sclerosis (ALS).
Clinical studies showed that the treatment attenuated deterioration
of the disease when compared to placebo. It has been previously
investigated for the treatment of ischemic stroke, reperfusion
Injury, and myocardial Infarction as it possesses antioxidant and
anti-apoptotic properties. Being a low molecular weight molecule
with good water and lipid-soluble properties, it is therapeutically
advantageous in crossing the blood-brain barrier to mediate
nootropic and neuroprotective effects.
| País: | China |
| N º de Modelo: | - |
| Precio FOB: | Obtener el precio más reciente |
| Lugar de origen: | China |
| Precio de pedido mínimo: | - |
| Cantidad de pedido mínimo: | 10 Kilogram |
| Detalle de embalaje: | 10kg/fabric drum, or customized |
| El tiempo de entrega: | 30 days |
| Capacidad de suministro: | 30000 Kilogram per Year |
| Tipo de pago: | T/T, L/C, D/P |
| Grupo de productos : | API |
